SI
SI
discoversearch

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor.  We ask that you disable ad blocking while on Silicon Investor in the best interests of our community.  If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.
Biotech / Medical : GUMM - Eliminate the Common Cold
 Public ReplyPrvt ReplyMark as Last ReadFilePrevious 10Next 10PreviousNext  
To: Hank who wrote (1209)10/27/1999 5:34:00 PM
From: Eric Fader  Read Replies (2) of 5582
 
I said "intelligence and guts." The intelligence part is knowing the difference between a likely grand slam and a bad risk. KIDE was a no-brainer, and so is GUMM, IMO. There is absolutely no Las Vegas mentality at work here. I'm sorry you're unable to "get it."

Also, KIDE was an interesting low-float value play even without Pokemon, and GUMM is an interesting low-float, heavily shorted growth play without Zicam. There were virtually no stocks similar to KIDE at that time, and GUMM is similarly "almost unique" right now. Name some of those hundred stocks you think are comparable.

Finally, your "down the tubes" remark is a blatant attempt to scare people, since any intelligent investor or trader uses appropriate stops. The risk/reward here, as I see it, is a few points vs. 50-100 points.
Report TOU ViolationShare This Post
 Public ReplyPrvt ReplyMark as Last ReadFilePrevious 10Next 10PreviousNext  

HomeMailHotSubjectMarksPeopleMarksKeepersSettings
Terms Of UseContact UsCopyright/IP PolicyPrivacy PolicyAbout UsFAQAdvertise on SI
© 2025 Knight Sac Media.  Data provided by Twelve Data, Alpha Vantage, and CityFALCON News